Skip to content
OpenCapital
Get started

Elevance Health ELV Increase (Decrease) in Collateral Held under Securities Lending

Increase (Decrease) in Collateral Held under Securities Lending at other companies

Voya Financial logo
Voya FinancialVOYA
$71M+138%
Elevance Health logo
Elevance HealthELV
$313M+7.9%
Aflac logo
AflacAFL
-$2.58B-162%
Humana logo
HumanaHUM
-$55M-131%
JPMorgan Chase logo
JPMorgan ChaseJPM
-$1.66B-109%
Axos Financial logo
Axos FinancialAX
$19.8M—

Other financials

Income statement

See full
Revenue$50.5B+1.4%
Gross profit$45.0B+1.1%
Net income$1.5B-16.1%
EPS (diluted)$6.71-13.1%

Balance sheet

See full
Cash & equivalents$10.2B+19.5%
Total debt$30.7B+7.5%
Total equity$44.9B+2.7%
Total assets$126.44B+3.7%

Cash flow

See full
Operating cash flow$1.9B-6.9%
CapEx$287.0M+7.5%
Free cash flow$1.6B-9.0%

Valuation

See full
Market cap$81.91B+27.2%
Enterprise value$102.34B+21.3%
P/E16.5×+4.5×
P/S0.4×+0.1×

Profitability

See full
Gross margin89.1%+0.4pp
Net margin2.5%-0.4pp
FCF margin3.2%+0.4pp

Returns & leverage

See full
Return on equity11.2%-1.3pp
Debt / equity0.7×0.0×
Current ratio1.5×+0.1×

Where this comes from

Reported directly by Elevance Health in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInCollateralHeldUnderSecuritiesLending.

The official record: Elevance Health’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Elevance Health's increase (decrease) in collateral held under securities lending.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Elevance Health's increase (decrease) in collateral held under securities lending?
Elevance Health (ELV) reported increase (decrease) in collateral held under securities lending of $313M in Q1 2026.
How has Elevance Health's increase (decrease) in collateral held under securities lending changed year-over-year?
Elevance Health's increase (decrease) in collateral held under securities lending increased by 7.9% year-over-year, from $290M to $313M.
What does increase (decrease) in collateral held under securities lending mean?
This metric represents the net change in cash or securities collateral received from counterparties in securities lending transactions. It reflects the company's liquidity management strategy regarding the temporary transfer of securities to earn fee income.